Evidence map›Paper›PMID 39941731›Full record

ArticleCancers2025

Ultra-High Dose Oral ω3 Eicosapentaenoic Acid (EPA), Docosahexaenoic Acid (DHA), or Oxidation-Resistant Deuterated DHA Block Tumorigenesis in a

Vishwa Patel, Yan Ning Li, Lorraine-Rana E Benhamou, Hui Gyu Park, Mariya Raleigh, J Thomas Brenna, John T Powers

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vishwa PatelDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.ORCID 0000-0003-0418-134X
Yan Ning LiDell Pediatric Research Institute, Department of Chemistry, College of Natural Sciences, The University of Texas at Austin, Austin, TX 78723, USA.ORCID 0009-0006-2119-2250
Lorraine-Rana E BenhamouDell Pediatric Research Institute, Department of Pediatrics, Dell Medical School, The University of Texas at Austin, Austin, TX 78723, USA.ORCID 0009-0002-6443-9269
Hui Gyu ParkDell Pediatric Research Institute, Department of Chemistry, College of Natural Sciences, The University of Texas at Austin, Austin, TX 78723, USA.ORCID 0000-0002-0510-2095
Mariya RaleighDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.ORCID 0009-0006-0975-2286
J Thomas BrennaDell Pediatric Research Institute, Department of Chemistry, College of Natural Sciences, The University of Texas at Austin, Austin, TX 78723, USA.ORCID 0000-0001-9494-4245
John T PowersDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.ORCID 0000-0003-1598-2417

Funding

Cancer Prevention and Research Institute of Texas (CPRIT) RR180034
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-tumorigenesisarachidonic aciddocosahexaenoic acideicosapentaenoic acidMYCNneuro-2aneuroblastomaomega-3syngeneic mouse

Identifiers

PMID39941731
PMCPMC11816027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.